Cardiovascular effects of resveratrol.
Institute of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia. l.g.bukarica@sezampro.rs
Ljiljana Gojković
LG
Bukarica
Institute of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Dragana
D
Protić
Serbian Academy of Sciences and Arts, Belgrade, Serbia.
Vladimir
V
Kanjuh
Institute of Physiology, University of Tuebingen, Germany.
Helmut
H
Heinle
Institute of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Radmila
R
Novakoviĉ
Clinical Hospital Center "Dr Dragisa Misović", Belgrade, Serbia.
Radisav
R
Sćepanović
D000975:Antioxidants / Q000494:pharmacology*; D002319:Cardiovascular System / Q000187:drug effects*; D006801:Humans; D000077185:Resveratrol; D013267:Stilbenes / Q000494:pharmacology*
D000975:Antioxidants; D013267:Stilbenes; D000077185:Resveratrol